On January 30, 2026, Safecare Bio-Tech held its 2025 Annual Work Summary Meeting, attended by the company's general manager, Mr. Qiu, and the management team.
The meeting reviewed Safecare's overall business performance and management achievements in 2025, while aligning strategic priorities for the year ahead. Department heads from Sales, R&D, Technical, Quality, Production, Finance, and Human Resources presented their annual results, key challenges, and clear action plans for 2026, all aligned with the company's strategic goals.
Despite a challenging market environment, Safecare remained focused on its core business and achieved steady progress in technological innovation, market expansion, and operational efficiency, strengthening its overall competitiveness.
Looking forward to 2026, Mr. Qiu emphasized a results-driven approach focused on addressing key challenges, advancing automation, and improving execution efficiency. The company will continue to strengthen management and organizational capabilities through process optimization, standardization, and digitalization, supporting long-term, sustainable growth.
The meeting marked both a review of past achievements and a strong starting point for Safecare's continued development in 2026.
